Found: 93
Select item for more details and to access through your institution.
Cellular localization of p-tau217 in brain and its association with p-tau217 plasma levels.
- Published in:
- Acta Neuropathologica Communications, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40478-021-01307-2
- By:
- Publication type:
- Article
Blood‐based biomarkers for Alzheimer's disease.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 1, p. 1, doi. 10.15252/emmm.202114408
- By:
- Publication type:
- Article
Tau PET correlates with different Alzheimer's disease‐related features compared to CSF and plasma p‐tau biomarkers.
- Published in:
- EMBO Molecular Medicine, 2021, v. 13, n. 8, p. 1, doi. 10.15252/emmm.202114398
- By:
- Publication type:
- Article
Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau.
- Published in:
- EMBO Molecular Medicine, 2021, v. 13, n. 6, p. 1, doi. 10.15252/emmm.202114022
- By:
- Publication type:
- Article
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 12, p. N.PAG, doi. 10.15252/emmm.201911170
- By:
- Publication type:
- Article
Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Associations among plasma, MRI, and amyloid PET biomarkers of Alzheimer's disease and related dementias and the impact of health‐related comorbidities in a community‐dwelling cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 6, p. 4159, doi. 10.1002/alz.13835
- By:
- Publication type:
- Article
Risk of Alzheimer's disease is associated with longitudinal changes in plasma biomarkers in the multi‐ethnic Washington Heights–Hamilton Heights–Inwood Columbia Aging Project (WHICAP) cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 3, p. 1988, doi. 10.1002/alz.13652
- By:
- Publication type:
- Article
Novel avenues of tau research.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 3, p. 2240, doi. 10.1002/alz.13533
- By:
- Publication type:
- Article
Exploring biomarker profiles of the cognitively unimpaired individuals in early tau PET Braak stage.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.077921
- By:
- Publication type:
- Article
Exploring biomarker profiles of the cognitively unimpaired individuals in early tau PET Braak stage.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081775
- By:
- Publication type:
- Article
Profiling baseline performance on the Longitudinal Early‐Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collection.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. S8, doi. 10.1002/alz.13160
- By:
- Publication type:
- Article
The Sporadic Early‐onset Alzheimer's Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early‐onset Alzheimer's Disease Study (LEADS) Cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. S74, doi. 10.1002/alz.13466
- By:
- Publication type:
- Article
Pathogenic variants in the Longitudinal Early‐onset Alzheimer's Disease Study cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. S64, doi. 10.1002/alz.13482
- By:
- Publication type:
- Article
Influence of amyloid and diagnostic syndrome on non‐traditional memory scores in early‐onset Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. S29, doi. 10.1002/alz.13434
- By:
- Publication type:
- Article
Amyloid and tau‐PET in early‐onset AD: Baseline data from the Longitudinal Early‐onset Alzheimer's Disease Study (LEADS).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. S98, doi. 10.1002/alz.13453
- By:
- Publication type:
- Article
White matter hyperintensities are higher among early‐onset Alzheimer's disease participants than their cognitively normal and early‐onset nonAD peers: Longitudinal Early‐onset Alzheimer's Disease Study (LEADS).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. S89, doi. 10.1002/alz.13402
- By:
- Publication type:
- Article
Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early‐Onset Alzheimer's Disease Study (LEADS) cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. S42, doi. 10.1002/alz.13344
- By:
- Publication type:
- Article
Cerebrospinal fluid biomarkers in the Longitudinal Early‐onset Alzheimer's Disease Study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. S115, doi. 10.1002/alz.13399
- By:
- Publication type:
- Article
Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 9, p. 4127, doi. 10.1002/alz.13314
- By:
- Publication type:
- Article
Plasma p‐tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 6, p. 2585, doi. 10.1002/alz.12906
- By:
- Publication type:
- Article
Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 4, p. 1403, doi. 10.1002/alz.12787
- By:
- Publication type:
- Article
Effect of APOE4 on Plasma Phospho‐tau 217 and Neurofilament Light in the PSEN1 E280A Autosomal Dominant Alzheimer's Disease Colombian Kindred.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.069090
- By:
- Publication type:
- Article
Plasma biomarkers associations with cognitive change in preclinical Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.068847
- By:
- Publication type:
- Article
Sex and APOE‐ε4 carrier effects on early‐onset Alzheimer's disease pathology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.068743
- By:
- Publication type:
- Article
A head‐to‐head comparison of plasma phosphorylated tau assays in the real‐world memory clinic.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.065391
- By:
- Publication type:
- Article
Head‐to‐head comparison between plasma ptau‐217 and Flortaucipir‐PET in amyloid‐positive patients with cognitive impairment.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.064837
- By:
- Publication type:
- Article
Value of plasma biomarkers to predict memory change in cognitively unimpaired individuals.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.061795
- By:
- Publication type:
- Article
Head‐to‐Head Comparison of Four Plasma Phospho‐Tau Immunoassays in the Neuropathological Diagnosis of Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.060336
- By:
- Publication type:
- Article
Comparison of C<sub>2</sub>N Diagnostics' Aβ40, 42, and 42/40 ratio in Plasma Stored in Micronic and Sarstedt Tubes.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.068067
- By:
- Publication type:
- Article
Association of Retinal Nerve Fiber Layer Thickness with Plasma pTau181 and Aβ42/Aβ40 ratio.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.067861
- By:
- Publication type:
- Article
Implementation of Blood‐Based Biomarker Assays to Deliver Consistent and Comparable Data.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.065790
- By:
- Publication type:
- Article
Head‐to‐head comparison between plasma ptau‐217 and Flortaucipir‐PET in amyloid‐positive patients with cognitive impairment.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, p. 1, doi. 10.1002/alz.067888
- By:
- Publication type:
- Article
Characterization of pre‐analytical sample handling effects on a panel of Alzheimer's disease–related blood‐based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 8, p. 1484, doi. 10.1002/alz.12510
- By:
- Publication type:
- Article
Comparison of CSF phosphorylated tau 181 and 217 for cognitive decline.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 4, p. 602, doi. 10.1002/alz.12415
- By:
- Publication type:
- Article
Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aβ42/Aβ40 and p‐tau.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 2, p. 283, doi. 10.1002/alz.12395
- By:
- Publication type:
- Article
Biomarker driven enrichment strategies for tau pathology in AD clinical trials.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055656
- By:
- Publication type:
- Article
Ability of tau‐PET, phospho‐tau217, NfL and cortical thickness to predict short‐term cognitive decline in early symptomatic Alzheimer’s disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.053054
- By:
- Publication type:
- Article
Associations between plasma p‐tau217, in vivo brain pathology and cognition in individuals with autosomal‐dominant Alzheimer's disease: Findings from the Colombia‐Boston (COLBOS) biomarker study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056260
- By:
- Publication type:
- Article
Plasma biomarkers predict longitudinal amyloid accumulation, tau burden, brain atrophy and cognitive decline in early Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055597
- By:
- Publication type:
- Article
Stability of the novel blood‐based biomarkers under pre‐analytical sample handling conditions: Results of the SABB‐GBSC working group.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055441
- By:
- Publication type:
- Article
The impact of cerebrovascular disease on blood‐based biomarkers of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055434
- By:
- Publication type:
- Article
Comparing the clinical utility and diagnostic performance of cerebrospinal fluid P‐tau181, P‐tau217 and P‐tau231 assays.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055316
- By:
- Publication type:
- Article
Development and analytical performance testing of a novel sTREM2 ELISA method to support drug development.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.054868
- By:
- Publication type:
- Article
Clinical and analytical comparison of three assays for plasma p‐tau isoforms on an ultrasensitive platform.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.054044
- By:
- Publication type:
- Article
Detecting amyloid positivity in early Alzheimer disease using plasma biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.052117
- By:
- Publication type:
- Article
Plasma P‐tau181 levels predict amyloid pathology in cognitively unimpaired individuals after 10 years.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.051727
- By:
- Publication type:
- Article
Soluble P‐tau217 reflects both amyloid and tau pathology in the human brain and mediates the association of amyloid with neocortical tau.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.050391
- By:
- Publication type:
- Article
Sex differences in blood‐based biomarkers in individuals with autosomal dominant Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 3, p. 1, doi. 10.1002/alz.055011
- By:
- Publication type:
- Article